Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $53B | +$467M | 124 | 0.96% | Increased |
|
| 2 |
BlackRock
New York
| $47.2B | +$270M | 133 | 0.99% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $23.5B | -$124M | 119 | 0.97% | Reduced |
|
| 4 |
Fidelity Investments
Boston,
Massachusetts
| $18.8B | -$2.22B | 109 | 1.2% | Reduced |
|
| 5 |
Capital World Investors
Los Angeles,
California
| $14.2B | +$33.9M | 12 | 2.31% | Increased |
|
| 6 |
T. Rowe Price Associates
Baltimore,
Maryland
| $13.2B | -$385M | 83 | 1.62% | Reduced |
|
| 7 |
Morgan Stanley
New York
| $12.3B | +$80.4M | 143 | 0.88% | Increased |
|
| 8 |
Geode Capital Management
Boston,
Massachusetts
| $12.2B | +$394M | 138 | 0.96% | Increased |
|
| 9 |
JP Morgan Chase
New York
| $12.2B | +$526M | 127 | 0.89% | Increased |
|
| 10 |
Wellington Management Group
Boston,
Massachusetts
| $9.55B | -$1.23B | 47 | 1.84% | Reduced |
|
| 11 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $8.6B | -$260M | 20 | 5.69% | Reduced |
|
| 12 |
Norges Bank
Oslo,
Norway
| $7.48B | -$176M | 28 | 1.05% | Reduced |
|
| 13 |
Capital International Investors
Los Angeles,
California
| $6.8B | -$1.44B | 9 | 1.34% | Reduced |
|
| 14 |
Capital Research Global Investors
Los Angeles,
California
| $6.44B | -$1.17B | 7 | 1.4% | Reduced |
|
| 15 |
Northern Trust
Chicago,
Illinois
| $6.15B | -$105M | 118 | 0.91% | Reduced |
|
| 16 |
Bank of America
Charlotte,
North Carolina
| $6.04B | +$469M | 144 | 0.49% | Increased |
|
| 17 |
Franklin Resources
San Mateo,
California
| $5.84B | -$93.2M | 59 | 1.68% | Reduced |
|
| 18 |
UBS AM
Chicago,
Illinois
| $4.74B | +$610M | 50 | 1.21% | Increased |
|
| 19 |
Bank of New York Mellon
New York
| $4.73B | -$254M | 94 | 0.94% | Reduced |
|
| 20 |
Goldman Sachs
New York
| $4.55B | +$288M | 110 | 0.74% | Increased |
|
| 21 |
Massachusetts Financial Services
Boston,
Massachusetts
| $4.48B | -$523M | 22 | 1.49% | Reduced |
|
| 22 |
Invesco
Atlanta,
Georgia
| $4.23B | +$599M | 84 | 0.8% | Increased |
|
| 23 |
Dimensional Fund Advisors
Austin,
Texas
| $4B | -$13.8M | 72 | 0.99% | Reduced |
|
| 24 |
Charles Schwab
San Francisco,
California
| $3.97B | +$122M | 97 | 0.74% | Increased |
|
| 25 |
UBS Group
Zurich,
Switzerland
| $3.88B | +$589M | 149 | 0.71% | Increased |
|